Now open for collaboration - Sweden’s large scale, integrated healthcare infrastructure with structured information and biobank samples from 9,000 cancer patients

Uppsala-based U-CAN, with its continuously growing repository of unique material from longitudinal studies, welcomes collaboration projects aimed at improving diagnosis, prognosis, treatment and ultimately patient outcomes. As of spring 2016, U-CAN has already initiated such collaborations with both leading pharmaceutical companies and international cancer institutes.

Tobias Sjöblom, Senior lecturer at Department of Immunology, Genetics and Pathology, Uppsala University